Cargando…

Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients

BACKGROUND: Immunotherapy has exhibited efficacy in thymic carcinoma patients; however, there are insufficient data to confirm this efficacy in thymoma. The toxicity of immunotherapy also remains to be determined. METHODS: The efficacy and safety of immunotherapy were analyzed in 11 thymoma patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Yue, Lin, Gen, Xiang, Jing, Wang, Wenxian, Xu, Chunwei, Wang, Qian, Cai, Jing, Zhang, Yongchang, Song, Zhengbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	BRIEF COMMUNICATION
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028091/ https://www.ncbi.nlm.nih.gov/pubmed/36394097 http://dx.doi.org/10.1002/cam4.5357

Ejemplares similares

Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma
por: Hao, Yue, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study
por: Xiang, Jing, et al.
Publicado: (2023)

Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements
por: Zhang, Yongchang, et al.
Publicado: (2022)

The efficacy and safety of anlotinib treatment for advanced lung cancer
por: Shao, Lan, et al.
Publicado: (2019)

Safety and efficacy of INTRABEAM intraoperative radiotherapy for invasive thymoma
por: Cui, Tian-xiang, et al.
Publicado: (2020)

Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study
por: Wang, Wenxian, et al.
Publicado: (2018)

Immunotherapy for thymoma
por: Jakopovic, Marko, et al.
Publicado: (2020)

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
por: Senti, G, et al.
Publicado: (2015)

Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
por: Wang, Wenxian, et al.
Publicado: (2022)

Comparison of efficacy and safety of second‐ and third‐generation TKIs for non‐small‐cell lung cancer with uncommon EGFR mutations
por: Hao, Yue, et al.
Publicado: (2023)

Treatment and prognosis of type B2 thymoma
por: Song, Zhengbo, et al.
Publicado: (2014)

Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
por: Gu, Xiaodong, et al.
Publicado: (2023)

Radiotherapy for stage IVa thymoma—Shanghai Chest experience
por: Wang, Changlu, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
por: Quilez, Alicia, et al.
Publicado: (2020)

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial
por: Song, Zhengbo, et al.
Publicado: (2022)

Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
por: Wei, Jingwen, et al.
Publicado: (2022)

A Rare Case of Mixed Type A Thymoma and Micronodular Thymoma with Lymphoid Stroma
por: Cha, Yoon Jin, et al.
Publicado: (2015)

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study
por: Gu, Xiaodong, et al.
Publicado: (2022)

Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study
por: Zhang, Yongchang, et al.
Publicado: (2021)

Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations
por: Si, Jinfei, et al.
Publicado: (2023)

Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
por: Lu, Mingdong, et al.
Publicado: (2021)

Effects of Serum Vitamin D and Efficacy of Subcutaneous Immunotherapy in Adult Patients With Allergic Rhinitis
por: Joudi, Maryam, et al.
Publicado: (2019)

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
por: Wang, Wenxian, et al.
Publicado: (2019)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

Expanding Spectrum of Toxoplasma gondii: Thymoma and Toxoplasmic Encephalitis
por: Chastain, Daniel B, et al.
Publicado: (2018)

Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis
por: Wang, Wenxian, et al.
Publicado: (2018)

Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series
por: Harris, Jessica P, et al.
Publicado: (2022)

A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR‐TKI resistance
por: Wang, Wenxian, et al.
Publicado: (2016)

Advances in the pathogenesis of Rett syndrome using cell models
por: Lu, Sijia, et al.
Publicado: (2022)

Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
por: Wang, Yang, et al.
Publicado: (2018)

Immune checkpoint inhibitors beyond first-line progression with prior immunotherapy in patients with advanced non-small cell lung cancer
por: Xu, Manyi, et al.
Publicado: (2023)

The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis
por: Guan, Yelan, et al.
Publicado: (2023)

Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
por: Han, Sujun, et al.
Publicado: (2023)

Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine
por: Fukami, Hirotaka, et al.
Publicado: (2023)

An unusual huge thymoma composed of sclerosing thymoma and type AB thymoma: A case report
por: Jiang, Yu-ting, et al.
Publicado: (2021)

Induction Strategy for Locally Advanced Thymoma
por: Zhang, Yang, et al.
Publicado: (2021)

Gene-Specific Methylation Analysis in Thymomas of Patients with Myasthenia Gravis
por: Lopomo, Angela, et al.
Publicado: (2016)

A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report
por: Zhou, Tao, et al.
Publicado: (2022)

Safety assessment of nanomaterials using an advanced decision-making framework, the DF4nanoGrouping
por: Landsiedel, Robert, et al.
Publicado: (2017)

Adenocarcinoma Arising in an Ectopic Hamartomatous Thymoma with HER2 Overexpression
por: Oh, Harim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_90abaeu6dc21mso4tvcn0s1ifj